Elena Schiopu

4.0k total citations
50 papers, 1.4k citations indexed

About

Elena Schiopu is a scholar working on Pathology and Forensic Medicine, Rheumatology and Immunology. According to data from OpenAlex, Elena Schiopu has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 16 papers in Rheumatology and 16 papers in Immunology. Recurrent topics in Elena Schiopu's work include Systemic Sclerosis and Related Diseases (21 papers), Inflammatory Myopathies and Dermatomyositis (14 papers) and Mast cells and histamine (8 papers). Elena Schiopu is often cited by papers focused on Systemic Sclerosis and Related Diseases (21 papers), Inflammatory Myopathies and Dermatomyositis (14 papers) and Mast cells and histamine (8 papers). Elena Schiopu collaborates with scholars based in United States, Hungary and Russia. Elena Schiopu's co-authors include Kristine Phillips, James R. Seibold, Dinesh Khanna, Aryeh Fischer, David A. Fox, Ann Impens, Vivien Hsu, Ganesh Raghu, Carlo Albera and Leland W.K. Chung and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Elena Schiopu

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Schiopu United States 21 646 398 301 299 275 50 1.4k
Serena Vettori Italy 23 1.0k 1.6× 476 1.2× 322 1.1× 387 1.3× 305 1.1× 58 1.6k
Alessandra Vacca Italy 22 748 1.2× 366 0.9× 253 0.8× 370 1.2× 155 0.6× 58 1.5k
Nezam Altorok United States 14 421 0.7× 222 0.6× 129 0.4× 330 1.1× 309 1.1× 49 1.1k
Paolo Fraticelli Italy 16 948 1.5× 323 0.8× 266 0.9× 866 2.9× 352 1.3× 38 2.1k
Chris T. Derk United States 23 1.1k 1.7× 491 1.2× 339 1.1× 268 0.9× 219 0.8× 64 1.7k
Giuseppina Farina United States 23 1.1k 1.7× 474 1.2× 365 1.2× 581 1.9× 503 1.8× 37 2.1k
A Scheja Sweden 24 1.2k 1.8× 489 1.2× 298 1.0× 383 1.3× 197 0.7× 57 1.6k
Yong Hou China 20 433 0.7× 250 0.6× 139 0.5× 316 1.1× 118 0.4× 77 1.0k
Torhild Garen Norway 23 859 1.3× 850 2.1× 645 2.1× 189 0.6× 202 0.7× 41 1.6k
Martial Koenig Canada 14 651 1.0× 162 0.4× 425 1.4× 291 1.0× 117 0.4× 39 1.1k

Countries citing papers authored by Elena Schiopu

Since Specialization
Citations

This map shows the geographic impact of Elena Schiopu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Schiopu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Schiopu more than expected).

Fields of papers citing papers by Elena Schiopu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Schiopu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Schiopu. The network helps show where Elena Schiopu may publish in the future.

Co-authorship network of co-authors of Elena Schiopu

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Schiopu. A scholar is included among the top collaborators of Elena Schiopu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Schiopu. Elena Schiopu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aggarwal, Rohit, Joachim Schessl, Zsuzsanna Bata‐Csörgõ, et al.. (2025). Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study. Rheumatology and Therapy. 12(5). 855–871.
2.
Ritchlin, Christopher T., Philip J. Mease, Wolf‐­Henning Boehncke, et al.. (2024). Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study. Clinical Rheumatology. 43(8). 2551–2563. 1 indexed citations
3.
4.
Jo, Janggun, David Mills, Aaron Dentinger, et al.. (2023). Photoacoustic Imaging of COVID-19 Vaccine Site Inflammation of Autoimmune Disease Patients. Sensors. 23(5). 2789–2789. 2 indexed citations
5.
6.
Chen, Xuan, Alison H. Affinati, Adina F. Turcu, et al.. (2022). Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes. Diabetes Care. 45(5). 1170–1176. 53 indexed citations
7.
8.
9.
10.
Zheutlin, Alexander R. & Elena Schiopu. (2018). Relapsing Polychondritis following Treatment with Secukinumab for Ankylosing Spondylitis: Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2018. 1–4. 3 indexed citations
11.
Martyanov, Viktor, Grace Hyun J. Kim, Wendy Hayes, et al.. (2017). Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease. PLoS ONE. 12(11). e0187580–e0187580. 58 indexed citations
12.
Schiopu, Elena, et al.. (2017). Case series: Monoarticular rheumatoid arthritis. European Journal of Rheumatology. 4(4). 264–267. 6 indexed citations
13.
Schiopu, Elena, Soumya Chatterjee, Vivien Hsu, et al.. (2016). Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study. Arthritis Research & Therapy. 18(1). 131–131. 60 indexed citations
14.
Khanna, Dinesh, Carlo Albera, Aryeh Fischer, et al.. (2016). An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial. The Journal of Rheumatology. 43(9). 1672–1679. 192 indexed citations
15.
Tsou, Pei‐Suen, Bradley J. Rabquer, Ray A. Ohara, et al.. (2015). Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines. Lara D. Veeken. 55(4). 745–754. 22 indexed citations
16.
Khanna, Dinesh, Carlo Albera, Aryeh Fischer, et al.. (2015). Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)–The LOTUSS study. OA4489–OA4489. 2 indexed citations
17.
Khanna, Dinesh, Carlo Albera, Aryeh Fischer, et al.. (2015). SAT0433 Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease – the Lotuss Study. Annals of the Rheumatic Diseases. 74. 816–816. 10 indexed citations
18.
Tsou, Pei‐Suen, George A. Zakhem, M. Asif Amin, et al.. (2014). Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts. Arthritis Research & Therapy. 16(4). 411–411. 19 indexed citations
19.
Schiopu, Elena, Maureen McMahon, Mariana J. Kaplan, et al.. (2013). Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Lara D. Veeken. 53(4). 704–713. 36 indexed citations
20.
Schiopu, Elena, Vivien Hsu, & Ann Impens. (2010). Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud's Phenomenon Secondary to Systemic Sclerosis. Journal of Vascular Surgery. 52(2). 519–519. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serena Vettori Breakdown of academic impact, for papers by Alessandra Vacca Breakdown of academic impact, for papers by Nezam Altorok Breakdown of academic impact, for papers by Paolo Fraticelli Breakdown of academic impact, for papers by Chris T. Derk Breakdown of academic impact, for papers by Giuseppina Farina Breakdown of academic impact, for papers by A Scheja Breakdown of academic impact, for papers by Yong Hou Breakdown of academic impact, for papers by Torhild Garen Breakdown of academic impact, for papers by Martial Koenig
Rankless by CCL
2026